Diagnosis and Management of Hypermobility Spectrum Disorders in Primary Care
Open accessAbstract
Hypermobility spectrum disorders (HSDs) encompass an array of connective tissue disorders characterized by joint instability and chronic pain. Fatigue and other systemic symptoms that affect daily functioning may occur, as well. Accurate data on incidence and prevalence of HSDs is hampered by lack of awareness of these conditions and the wide heterogeneity of their clinical presentation. Identifying which type of HSD is present is important in guiding appropriate care. In particular, making the diagnosis of hypermobile Ehlers-Danlos syndrome (hEDS) is important, as individuals with hEDS may be at risk for more significant multisystem involvement. Diagnostic criteria for hEDS include measures of joint hypermobility, skin and other connective tissue findings, and lack of evidence of a different type of Ehlers-Danlos syndrome. Beyond accurate diagnosis, HSDs pose many challenges for primary care providers, as ongoing patient education, patient empowerment, and coordination of a multidisciplinary treatment team are integral to proper care. This article describes the incidence and prevalence, pathophysiology, diagnosis, and management of HSDs, including clinical cases exemplifying how joint hypermobility might present within a primary care setting.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 52 cited sources checked · 0 supported · 0 flagged
- Premisecitation
In college-aged populations, the incidence of hypermobile joints is higher than in older adults.
“In these college-aged populations, the incidence of hypermobile joints was higher than that in older adults.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [8]
Not checked in the free run.
- cites [9]
Not checked in the free run.
- Premisecitation
A validated patient questionnaire for hypermobility symptoms, with at least two affirmative answers out of five, has 84% sensitivity and 80% specificity for joint hypermobility.
“On a validated, commonly used patient questionnaire eliciting hypermobility symptoms, an affirmative answer to 2 or more out of 5 questions shows 84% sensitivity and 80% specificity for joint hypermobility (Table 1).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Table 1
Not checked in the free run.
- Premisecitation
Kirk and colleagues in 1967 described hypermobility syndrome as familial ligamentous laxity causing recurrent joint pain and periodic joint effusion.
“Kirk and colleagues first described hypermobility syndrome in 1967, describing a syndrome of familial ligamentous laxity resulting in recurrent joint pain and periodic joint effusion.4”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [4]
Not checked in the free run.
- Premisecitation
Joint hypermobility is more common in patients diagnosed with anxiety.
“Joint hypermobility is more common in patients diagnosed with anxiety, 24”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [24]
Not checked in the free run.
- Premisereasoning
Children of HSD patients may have up to a 50% chance of some degree of hypermobility, given evidence of autosomal dominant inheritance with variable penetrance.
“Given evidence of an autosomal dominant inheritance pattern with variable penetrance, children of HSD patients may have up to a 50% chance of hypermobility of some degree.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [10]
Not checked in the free run.
- cites [11]
Not checked in the free run.
- Rests on an assumption: There is some elevated risk of late-pregnancy back or sacroiliac pain and some risk of early labor in hEDS and probably in HSDs.
- Premisecitation
Primary care can manage most HSD or hEDS patients with a multidisciplinary approach comprising physical therapy, biofeedback, cognitive behavioral therapy or psychotherapy, and pharmacotherapy.
“Once the diagnosis of HSD or hEDS is suspected or confirmed, the majority of patients can be managed in the primary care setting with a multidisciplinary approach that involves physical therapy, biofeedback, cognitive behavioral therapy/psychotherapy, and pharmacotherapy.31”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [31]
Not checked in the free run.
- Premisecitation
There is no evidence of increased risks of adverse pregnancy outcomes in pregnant women with HSDs.
“There is a paucity of research to guide clinicians, but no evidence of increased risks of adverse pregnancy outcomes.22,23”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [22]
Not checked in the free run.
- cites [23]
Not checked in the free run.
- Rests on an assumption: There is some elevated risk of late-pregnancy back or sacroiliac pain and some risk of early labor in hEDS and probably in HSDs.
- Premisecitation
Participants with joint hypermobility had significant differences on MRI in brain regions associated with anxiety compared with nonhypermobile participants.
“Eccles and colleagues found that participants with joint hypermobility had significant differences on magnetic resonance imaging (MRI) in brain regions associated with anxiety in comparison to nonhypermobile participants.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [28]
Not checked in the free run.
- Premisecitation
Bruising and bleeding in HSD are caused by fragile skin and capillaries rather than abnormal coagulation.
“Bruising and bleeding in people with HSD occur due to fragile skin and capillaries rather than abnormal coagulation.19”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [19]
Not checked in the free run.
- Premisecitation
In HSD patients, treating dysautonomia may lead to improvement in both fatigue and pain.
“Treating dysautonomia in patients with HSD may improve both fatigue and pain.32”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [32]
Not checked in the free run.
- Rests on an assumption: Fatigue and pain are associated, which reduces quality of life.
- Premisecitation
Hypermobile subjects had significantly enlarged amygdalae bilaterally compared with the nonhypermobile cohort.
“Hypermobile subjects had significantly enlarged amygdalae bilaterally in comparison to the nonhypermobile cohort.28”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [28]
Not checked in the free run.
- Premisecitation
In a follow-up reverse case-control study, joint hypermobility was found at 17 times the incidence in patients diagnosed with anxiety compared with age- and gender-matched controls without anxiety.
“In the follow-up reverse case-control study, joint hypermobility was found at 17 times the incidence in patients diagnosed with anxiety as compared with age-and gender-matched controls without an anxiety diagnosis.27”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [27]
Not checked in the free run.
- Interpretationreasoning
A blanket recommendation to increase physical activity may exacerbate symptoms in people with HSD because of postexercise malaise.
“Coupled with the postexercise malaise that many people with HSD report, a blanket recommendation to increase physical activity may actually exacerbate symptoms.”
Quote in the paperSubstantial claim - Premisecitation
The Simple Questionnaire to Detect Hypermobility has 84% sensitivity and 85% specificity for HSD.
“Using the aptly named “A Simple Questionnaire to Detect Hypermobility” can help streamline an initial evaluation, as it has a sensitivity of 84% and specificity of 85% for HSD. 1”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [1]
Not checked in the free run.
- Interpretationreasoning
In anxious people with HSD, physical activity may not have the intended anxiolytic effect.
“While physical activity is often recommended for patients with anxiety, such activity in anxious people with HSD may not have the intended effect.”
Quote in the paperSubstantial claim - Premisecitation
Anxiety is disproportionately present in people with joint hypermobility.
“and anxiety is disproportionately present in people with joint hypermobility.25,26”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [25]
Not checked in the free run.
- cites [26]
Not checked in the free run.
- Premisecitation
Problems with autonomic function such as orthostatic intolerance, body temperature dysregulation, and exercise intolerance are common in people with HSD.
“Problems with autonomic function, such as orthostatic intolerance (ie, postural orthostatic tachycardia syndrome), body temperature dysregulation, and exercise intolerance, are common in people with HSD.29,30”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [29]
Not checked in the free run.
- cites [30]
Not checked in the free run.
- Premisecitation
In a study of patients with joint hypermobility, anxiety was found in 70% compared with 20% in age- and gender-matched controls.
“In a study of patients with joint hypermobility, anxiety was found in 70% of patients in comparison with a 20% incidence in the age-and gendermatched control group.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [27]
Not checked in the free run.
- Premisecitation
The authors found structural differences in the anterior cingulate cortex, a brain structure associated with cognitive control of emotions and autonomic arousal.
“In addition, the authors found structural differences in the anterior cingulate cortex, another brain structure associated with cognitive control of emotions and a driver of autonomic arousal.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [28]
Not checked in the free run.
- Interpretationnone given
After diagnosis, HSD and hEDS are treated the same way.
“However, once a diagnosis is made, there is no difference in the approach to treatment for HSD and hEDS (Table 6).”
Quote in the paperSubstantial claim- Rests on an assumption: HSD and hEDS lie on a single physiologic spectrum, with hEDS representing the more symptomatic end.
- May combine two claims. 17
- Classified as probably not a substantial claim. 7
May combine two claims.
Premisenone givenAt the same time, type III EDS was renamed hypermobile EDS and given new diagnostic criteria that better distinguish it from G-HSD.
“At the same time, type III EDS was renamed hypermobile EDS (hEDS) and given a new set of diagnostic criteria that better differentiate it from G-HSD (Table 3).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Table 3
Not checked in the free run.
May combine two claims.
PremisecitationHSDs have a strong genetic basis but no known genetic markers.
“HSDs have a strong genetic basis but no known genetic markers.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [10]
Not checked in the free run.
- cites [11]
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe Beighton hypermobility score is commonly used in the assessment of hypermobile patients.
“The physical examination-based counterpart to this questionnaire is the Beighton hypermobility score (Table 2), which is commonly employed in the assessment of the hypermobile patient.3”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [3]
Not checked in the free run.
- Rests on an assumption: Higher Beighton scores reflect the number of affected joints rather than the degree of joint laxity.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationA recent UK symptom-based survey estimated the prevalence of HSDs in the general population at 3%.
“A more recent UK symptom-based survey estimated prevalence of HSDs in a general population at 3%. 10”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [10]
Not checked in the free run.
- Rests on an assumption: Accurate incidence and prevalence data for HSDs are hampered by lack of awareness and heterogeneity of clinical presentation.
May combine two claims.
PremisecitationThe Beighton scoring rubric was originally created for epidemiologic research rather than diagnosis, but it is now used as a measure of generalized hypermobility.
“Though the Beighton hypermobility scoring rubric was initially introduced as an instrument for epidemiologic research rather than a tool to be used diagnostically, it has now come to be used as a measure of generalized hypermobility. 2”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [2]
Not checked in the free run.
- Rests on an assumption: Higher Beighton scores reflect the number of affected joints rather than the degree of joint laxity.
May combine two claims.
PremisecitationIn 2017, benign joint hypermobility syndrome was reclassified and renamed hypermobility spectrum disorders, with generalized, peripheral, localized, and historic subtypes.
“In 2017, JHS was reclassified and renamed the hypermobility spectrum disorders, 5 which are subcategorized into generalized (G-HSD), peripheral (P-HSD), localized (L-HSD), and historic (H-HSD) types.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [5]
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationH-HSD is diagnosed when there is documented prior hypermobility that has disappeared with increasing age.
“H-HSD is diagnosed in cases of documented prior hypermobility that has disappeared with increased age.7”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [7]
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationPrevalence of generalized joint hypermobility among college-aged students is between 12.5% and 26%.
“Prevalence of generalized joint hypermobility among college-aged students ranges from 12.5% to 26%.8,9”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [8]
Not checked in the free run.
- cites [9]
Not checked in the free run.
- Rests on an assumption: Accurate incidence and prevalence data for HSDs are hampered by lack of awareness and heterogeneity of clinical presentation.
Classified as probably not a substantial claim.
PremisecitationHSDs are defined by joint hypermobility on the Beighton score plus one or more secondary musculoskeletal manifestations such as post-traumatic symptoms, pain, altered proprioception, pes planus, kyphosis, scoliosis, or joint misalignment.
“The HSDs are defined by joint hypermobility using the Beighton score (Table 2) plus 1 or more secondary musculoskeletal manifestations including post-traumatic symptoms, pain, altered proprioception, and a variety of other characteristics like pes planus, kyphosis, scoliosis, or joint misalignment.6”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [6]
Not checked in the free run.
- Rests on an assumption: Higher Beighton scores reflect the number of affected joints rather than the degree of joint laxity.
May combine two claims.
PremisecitationFactors likely contributing to pain generation and chronicity in HSD include nociceptive pain from structural changes, neuropathic pain, impaired proprioception and muscle weakness, and central sensitization.
“Factors likely contributing to the generation and chronicity of pain include nociceptive pain due to structural changes in affected joints, muscle, and connective tissue; neuropathic pain; impaired proprioception and muscle weakness; and central sensitization.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [12]
Not checked in the free run.
- Rests on an assumption: The specific causes and mechanisms of pain in HSD are poorly understood.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationMany consider HSDs and hEDS to be a single clinical entity, with variable manifestations possibly reflecting variability in penetrance.
“In view of the considerable clinical overlap with HSDs, many consider HSDs and hEDS to be a single clinical entity, with variable manifestations possibly reflecting variability in penetrance.12”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [12]
Not checked in the free run.
May combine two claims.
PremisecitationPharmacotherapy for HSD/hEDS follows the same principles as for most chronic pain conditions, avoiding opioids and preferring NSAIDs/acetaminophen, topical NSAIDs, lidocaine patches for neuropathic pain, antidepressants (SNRIs or low-dose TCAs), and/or anticonvulsants.
“The tenets of pharmacotherapy are similar to those in most chronic pain conditions with avoidance of opioids, preference for nonsteroidal anti-inflammatory drugs (NSAIDs)/ acetaminophen, topical NSAIDs, lidocaine patches where neuropathic pain is present, antidepressants (particularly SNRIs or low-dose tricyclic antidepressants [TCAs]), and/or anticonvulsants.31”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [31]
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationLaxity indicates instability, while hypermobility means increased joint range of motion beyond normal.
“While these 2 terms are often used interchangeably, laxity indicates instability, whereas hypermobility denotes an increase in the joint's range of motion beyond normal.20”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [20]
Not checked in the free run.
May combine two claims.
PremisecitationCore and periarticular strengthening through physical and occupational therapy can enhance proprioception, lower injury risk, and decrease pain while boosting function.
“Physical and occupational therapy programs centered on strengthening the core and periarticular musculature can improve proprioception, reduce injury, and reduce pain while improving function (see Table 7).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites 10,[33][34][35][36][37][38][39]
Not checked in the free run.
May combine two claims.
PremisecitationHSD complaints may include autonomic dysfunction and cardiovascular concerns, gastrointestinal issues, anxiety, phobic disorders, major depression, headaches, and chronic fatigue.
“These complaints may include manifestations of autonomic dysfunction and other cardiovascular concerns, 29 a wide range of gastrointestinal issues, 21 anxiety, phobic disorders, major depression, 25 headaches and chronic fatigue, 10 among others.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [29]
Not checked in the free run.
- cites [21]
Not checked in the free run.
- cites [25]
Not checked in the free run.
- Rests on an assumption: The patient with HSD often has complaints involving multiple organ systems.
- Rests on an assumption: Many symptoms that bring HSD patients to care are not captured by the validated hypermobility questionnaire.
May combine two claims.
PremisecitationFear of provoking pain and injury may lead to activity avoidance, deconditioning, and exercise intolerance.
“Fear of provoking pain and injury may lead to avoidance of activity, ultimately resulting in deconditioning and exercise intolerance.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [16]
Not checked in the free run.
- cites [18]
Not checked in the free run.
May combine two claims.
PremisecitationPatients with hEDS generally present at a younger age and have more severe symptoms than HSD, and must meet the 2017 international diagnostic criteria.
“Patients with hEDS generally present to a physician's office at a younger age, have more severe symptoms, and must conform to strict diagnostic criteria put forth in 2017 by the International Consortium on Ehlers-Danlos Syndromes and Related Disorders.3”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [3]
Not checked in the free run.
May combine two claims.
PremisecitationHSD patients tend to have decreased muscle mass and strength, potentially because lax tendons cannot transmit muscle power.
“In addition, patients tend to have decreased muscle mass and muscle strength, potentially due to increased laxity of tendons, which are unable to transmit power produced by muscles.15,16”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [15]
Not checked in the free run.
- cites [16]
Not checked in the free run.
May combine two claims.
PremisecitationMost HSD cases are not linked to an identifiable mutation, though pedigree studies show a weak autosomal dominant inheritance pattern with variable penetrance.
“The vast majority of cases do not seem to be linked to any identifiable mutation, although pedigree studies have shown a weak autosomal dominant inheritance pattern with variable penetrance.10,11”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [10]
Not checked in the free run.
- cites [11]
Not checked in the free run.
May combine two claims.
PremisecitationHSD patients tend to lack proprioceptive acuity, which may increase their risk of injury.
“HSD patients tend to lack proprioceptive acuity, which may increase risk of injury.14”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [14]
Not checked in the free run.
May combine two claims.
PremisecitationDeconditioning and exercise intolerance often worsen functional disability and lead to anxiety and depression, which reduce pain tolerance and promote further pain.
“This often aggravates functional disability and leads to anxiety and depression symptoms, which in turn reduce pain tolerance and promote further pain.16,18”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [16]
Not checked in the free run.
- cites [18]
Not checked in the free run.
May combine two claims.
PremisecitationChildren and young adults with HSD may present with scoliosis, pes planus, genu valgum, genu recurvatum, and/or patellar dislocation or subluxation.
“Children and young adults may present with scoliosis, pes planus, genu valgum, genu recurvatum, and/or patellar dislocation/subluxation. 10”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [10]
Not checked in the free run.
The paper relies on this without support.
Higher Beighton scores reflect the number of affected joints rather than the degree of joint laxity.
“Higher scores on the Beighton scale simply represent a greater number of affected joints rather than a higher degree of laxity.”
The paper relies on this without support.
The patient with HSD often has complaints involving multiple organ systems.
“The patient with HSD will often have a range of complaints involving multiple organ systems.”
The paper relies on this without support.
Many symptoms that bring HSD patients to care are not captured by the validated hypermobility questionnaire.
“Many of these are not included in the validated questionnaire for hypermobility, and these are often the symptoms that draw the attention of patients and cause them to seek care.”
The paper relies on this without support.
Accurate incidence and prevalence data for HSDs are hampered by lack of awareness and heterogeneity of clinical presentation.
“Accurate data on incidence and prevalence of HSDs is hampered by lack of awareness of these conditions and the wide heterogeneity of their clinical presentation.”
The paper relies on this without support.
The specific causes and mechanisms of pain in HSD are poorly understood.
“The specific underlying causes and mechanisms of pain in HSD remain poorly understood.”
The paper relies on this without support.
There is some elevated risk of late-pregnancy back or sacroiliac pain and some risk of early labor in hEDS and probably in HSDs.
“There is some elevated risk of late-pregnancy back or sacroiliac pain, along with some risk of early labor, in hEDS and probably in the HSDs.”
The paper relies on this without support.
HSD and hEDS lie on a single physiologic spectrum, with hEDS representing the more symptomatic end.
“HSD and hEDS exist on the same physiologic continuum, but hEDS manifests at the more symptomatic edge of the spectrum.”
The paper relies on this without support.
Fatigue and pain are associated, which reduces quality of life.
“It should also be noted that fatigue and pain seem to be linked, leading to decreased quality of life.”
The paper relies on this without support.
Primary care clinicians commonly encounter patients with hypermobility spectrum disorders.
“Primary care clinicians will frequently see patients with hypermobility syndrome disorders.”
The paper relies on this without support.
HSD diagnosis is clinical and does not require laboratory or imaging tests for confirmation.
“While the initial workup for HSD involves eliminating other potential etiologies, the diagnosis is ultimately clinical and requires no laboratory or imaging tests for confirmation.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Biomechanical overloading and chronic soft tissue injury likely lead to soft tissue injury manifesting as localized joint arthralgias (nociceptive pain) and, in some, over time, diffuse musculoskeletal pain (central sensitization).
“This likely leads to soft tissue injury manifesting as localized joint arthralgias (nociceptive pain) and in some, over time, diffuse musculoskeletal pain (central sensitization).[2,8,24,25]”
From Hypermobility spectrum disorders: A review (2023) · cites this paper as [2]
Current theories emphasize localized biomechanical overloading and chronic soft tissue injury due to joint laxity and instability as environmental factors in HSDs.
“For environmental factors, current theories emphasize localized biomechanical overloading and chronic soft tissue injury due to joint laxity and instability.[2]”
From Hypermobility spectrum disorders: A review (2023) · cites this paper as [2]
Up until 2017, the clinical syndrome of symptomatic joint hypermobility was called joint hypermobility syndrome (JHS) or benign joint hypermobility syndrome (BJHS).
“Up until 2017 this clinical syndrome was called the joint hyper-mobility syndrome (JHS) or benign joint hypermobility syndrome (BJHS).[2,3]”
From Hypermobility spectrum disorders: A review (2023) · cites this paper as [2]
Studies of college students (typical ages between 18 and 24) report a GJH prevalence between 11%-12.5% and other studies between 12.5%-26%.
“Studies of “college students” (typical ages between 18 and 24) report a GJH prevalence between 11%-12.5%[16,17] and other between 12.5%-26%.[2,18,19]”
From Hypermobility spectrum disorders: A review (2023) · cites this paper as [2]
Patients with comorbid fibromyalgia may benefit from gabapentin or pregabalin.
“Patients with comorbid fibromyalgia may benefit from gabapentin or pregabalin.[2]”
From Hypermobility spectrum disorders: A review (2023) · cites this paper as [2]
hEDS and HSD exist on the same physiological continuum, with hEDS being a more marked form.
“very recent studies consider that hEDS and HSD exist on the same physiological continuum (hEDS being a more marked form) [22]”
From Are patients with hypermobile Ehlers–Danlos syndrome or hypermobility spectrum disorder so different? (2021) · cites this paper as [22]
Cites
The 2017 international classification of the Ehlers–Danlos syndromes
Malfait, F., Francomano, C., Byers, P., Belmont, J., Berglund, B., Black, J., Bloom, L., Bowen, J. M., Brady, A. F., Burrows, N. P., et al. (2017) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.31552 · Cited by 1,936 · see citing works
A framework for the classification of joint hypermobility and related conditions
Castori, M., Tinkle, B., Levy, H., Grahame, R., Malfait, F., & Hakim, A. (2017) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.31539 · Cited by 602 · cited 1× · see citing works
“H-HSD is diagnosed in cases of documented prior hypermobility that has disappeared with increased age.(7)”
BackgroundKirk, J. A., Ansell, B. M., & Bywaters, E. G. (1967) · Annals of the Rheumatic Diseases · doi:10.1136/ard.26.5.419 · Cited by 468 · see citing works
Dysautonomia in the joint hypermobility syndrome
Gazit, Y., Nahir, A. M., Grahame, R., & Jacob, G. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(03)00235-3 · Cited by 390 · see citing works
Hakim, A., & Grahame, R. (2003) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2003.tb10455.x · Cited by 312 · cited 4× · see citing works
“If signi fi - cant hypermobility is present on the Beighton hypermobility score, but a patient does not fi t the criteria for hEDS or another of the EDSs, the patient is diagnosed as G-HSD.”
BackgroundInfluentialPain management in the Ehlers–Danlos syndromes
Chopra, P., Tinkle, B., Hamonet, C., Brock, I., Gompel, A., Bulbena, A., & Francomano, C. (2017) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.31554 · Cited by 209 · see citing works
Ferrell, W. R., Tennant, N., Sturrock, R. D., Ashton, L., Creed, G., Brydson, G., & Rafferty, D. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20582 · Cited by 206 · see citing works
Generalized Joint Hypermobility and Risk of Lower Limb Joint Injury During Sport
Pacey, V., Nicholson, L. L., Adams, R. D., Munn, J., & Munns, C. F. (2010) · The American Journal of Sports Medicine · doi:10.1177/0363546510364838 · Cited by 193 · see citing works
Benign joint hypermobility syndrome: evaluation, diagnosis, and management.
Simpson, M. R. (2006) · PubMed · Cited by 174 · see citing works
Cardiovascular autonomic dysfunction in Ehlers–Danlos syndrome—Hypermobile type
Hakim, A., O'Callaghan, C., De Wandele, I., Stiles, L., Pocinki, A., & Rowe, P. (2017) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.31543 · Cited by 163 · see citing works
Castori, M., Morlino, S., Celletti, C., Ghibellini, G., Bruschini, M., Grammatico, P., Blundo, C., & Camerota, F. (2013) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36315 · Cited by 159 · see citing works
Joint Hypermobility Syndrome: Recognizing a Commonly Overlooked Cause of Chronic Pain
Kumar, B., & Lenert, P. (2017) · The American Journal of Medicine · doi:10.1016/j.amjmed.2017.02.013 · Cited by 153 · cited 4× · see citing works
“A more recent UK symptom-based survey estimated prevalence of HSDs in a general population at 3%.(10)”
BackgroundInfluentialRussek, L. N., & Errico, D. M. (2016) · Clinical Rheumatology · doi:10.1007/s10067-015-2951-9 · Cited by 143 · see citing works
Association Between Joint Hypermobility Syndrome and Panic Disorder
Martín‐Santos, R., Bulbena, A., Porta, M. S., Gago, J., Balaguer, L. M., & Duró, J. C. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.11.1578 · Cited by 137 · see citing works
Rombaut, L., Malfait, F., Wandele, I. D., Taes, Y., Thijs, Y., Paepe, A. D., & Calders, P. (2012) · Arthritis Care & Research · doi:10.1002/acr.21726 · Cited by 130 · see citing works
Anxiety disorders in the joint hypermobility syndrome
Bulbena, A., Duró, J. C., Porta, M., Martín-Santos, R., Mateo, A., Molina, L., Vallescar, R., & Vallejo, J. (1993) · Psychiatry Research · doi:10.1016/0165-1781(93)90008-5 · Cited by 118 · see citing works
Joint hypermobility and skin elasticity: the hereditary disorders of connective tissue
Hakim, A. J., & Sahota, A. (2006) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2006.07.013 · Cited by 114 · see citing works
Reuter, P. R., & Fichthorn, K. R. (2019) · PeerJ · doi:10.7717/peerj.7625 · Cited by 110 · see citing works
Scheper, M., de Vries, J. E., Verbunt, J., & Engelbert, R. H. H. (2015) · Journal of Pain Research · doi:10.2147/jpr.s64251 · Cited by 105 · see citing works
Brain structure and joint hypermobility: Relevance to the expression of psychiatric symptoms
Eccles, J. A., Beacher, F. D. C., Gray, M. A., Jones, C. L., Minati, L., Harrison, N. A., & Critchley, H. D. (2012) · British Journal of Psychiatry · doi:10.1192/bjp.bp.111.092460 · Cited by 96 · see citing works
Rombaut, L., Scheper, M., De Wandele, I., De Vries, J., Meeus, M., Malfait, F., Engelbert, R., & Calders, P. (2015) · Clinical Rheumatology · doi:10.1007/s10067-014-2499-0 · Cited by 91 · see citing works
Beckers, A. B., Keszthelyi, D., Fikree, A., Vork, L., Masclee, A., Farmer, A. D., & Aziz, Q. (2017) · Neurogastroenterology & Motility · doi:10.1111/nmo.13013 · Cited by 90 · see citing works
(2017) · PubMed · Cited by 90 · see citing works
JOINT HYPERMOBILITY SYNDROME AND ANXIETY DISORDERS
Bulbena, A., Duró, J. C., Mateo, A., Porta, M. S., & Vallejo, J. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90514-4 · Cited by 77 · see citing works
Simmonds, J. V., & Keer, R. J. (2008) · Manual Therapy · doi:10.1016/j.math.2007.11.001 · Cited by 68 · see citing works
Fikree, A., Aziz, Q., & Grahame, R. (2013) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2013.03.003 · Cited by 63 · see citing works
Symptomatic Joint Hypermobility
Tinkle, B. T., & Levy, H. P. (2019) · Medical Clinics of North America · doi:10.1016/j.mcna.2019.08.002 · Cited by 58 · see citing works
Hypermobile Ehlers–Danlos syndrome and pregnancy
Karthikeyan, A., & Venkat-Raman, N. (2018) · Obstetric Medicine · doi:10.1177/1753495x18754577 · Cited by 37 · see citing works
Pregnancy outcome in joint hypermobility syndrome and Ehlers–Danlos syndrome
Sundelin, H. E. K., Stephansson, O., Johansson, K., & Ludvigsson, J. F. (2016) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.13043 · Cited by 30 · see citing works
Kinematics and kinetics of people who are hypermobile. A systematic review
Bates, A. V., & Alexander, C. M. (2015) · Gait & Posture · doi:10.1016/j.gaitpost.2015.01.009 · Cited by 26 · see citing works
Rombaut, L., Scheper, M. C., Wandele, I. D., de Vries, J., Meeus, M., Malfait, F., Engelbert, R., & Calders, P. (2014) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2014.02.769 · Cited by 18 · see citing works
Joint mobility and Ehlers-Danlos syndrome, (EDS) new data based on 232 cases
I Brock, C. H. (2015) · Journal of Arthritis · doi:10.4172/2167-7921.1000148 · Cited by 11 · see citing works
Hamonet, C., Laouar, R., Vienne, M., Brissot, R., Bernard, J. C., & Comberg, A. (2010) · Journal de Réadaptation Médicale Pratique et Formation en Médecine Physique et de Réadaptation · doi:10.1016/j.jrm.2010.10.002 · Cited by 7 · see citing works
Joint Hypermobility, Anxiety, and Psychosomatics — The New Neuroconnective Phenotype
Pailhez, G., Castaño, J., Rosado, S., Ballester, M. D. M., Vendrell, C., Mallorquí‐Bagué, N., Baeza‐Velasco, C., & Bulbena, A. (2015) · InTech eBooks · doi:10.5772/60607 · Cited by 3 · see citing works
Flagged first, then by citations
1 of the 36 references couldn’t be matched to a known paper.
Research works printed but not linked: 5
- Fikree A, Aziz Q, Grahame R. Joint hypermobility syn- drome. Rheum Dis Clin North Am 2013;39:419-30.
- Tinkle BT, Levy HP. Symptomatic joint hypermo- bility: the hypermobile type of Ehlers-Danlos syn- drome and the hypermobility spectrum disorders. Med Clin North Am 2019;103:1021-33.
- Hauser RA, Phillips HJ. Treatment of joint hypermo- bility syndrome, including Ehlers-Danlos syndrome, with Hackett-Hemwall prolotherapy. Journal of Prolo 2011;3:612-29.
- Chopra P, Tinkle B, Hamonet C, et al. Pain man- agement in the Ehlers-Danlos syndromes. Am J Med Genet C Semin Med Genet 2017;175:212-9.
- Ferrell WR, Tennant N, Sturrock RD, et al Amelioration of symptoms by enhancement of pro- prioception in patients with joint hypermobility syndromes. Arthritis Rheumatism 2004;50:3323-8. 848 JABFM July-August 2021 Vol. 34 No. 4 http://www.jabfm.org on 20 August 2023 by guest. Protected by copyright. http://www.jabfm.org/ J Am Board Fam Med: first published as 10.3122/jabfm.2021.04.200374 on 26 July 2021. Downloaded from
Cited by
Sorted by citations
Aubry-Rozier, B., Schwitzguebel, A., Valerio, F., Tanniger, J., Paquier, C., Berna, C., Hügle, T., & Benaim, C. (2021) · Rheumatology International · doi:10.1007/s00296-021-04968-3 · Cited by 66 · see citing works
“In the same vein, very recent studies consider that hEDS and HSD exist on the same physiological continuum (hEDS being a more marked form) [22], require the same pattern of multidisciplinary intervention [23, 24], or are gathered in the same category for research purposes [25, 26].”
BackgroundHypermobility spectrum disorders: A review
Carroll, M. B. (2023) · Rheumatology and Immunology Research · doi:10.2478/rir-2023-0010 · Cited by 45 · see citing works
Donaghy, B., Moore, D., & Green, J. (2023) · Child Care in Practice · doi:10.1080/13575279.2022.2149471 · Cited by 37 · see citing works
Management of Shoulder Instability in Patients with Underlying Hyperlaxity
Rupp, M., Rutledge, J. C., Quinn, P. M., & Millett, P. J. (2023) · Current Reviews in Musculoskeletal Medicine · doi:10.1007/s12178-023-09822-6 · Cited by 28 · see citing works
Estrella, E., & Frazier, P. A. (2023) · Disability and Rehabilitation · doi:10.1080/09638288.2023.2176554 · Cited by 25 · see citing works
Ritelli, M., Chiarelli, N., Cinquina, V., Vezzoli, M., Venturini, M., & Colombi, M. (2023) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.63426 · Cited by 22 · see citing works
Sidonio, R. F., Bryant, P., Paola, J. D., Hale, S. A., Heiman, M., Horowitz, G. S., Humphrey, C., Jaffray, J., Joyner, L. C., Kasthuri, R. S., et al. (2023) · Expert Review of Hematology · doi:10.1080/17474086.2023.2171983 · Cited by 20 · see citing works
Ritelli, M., Chiarelli, N., Cinquina, V., Zoppi, N., Bertini, V., Venturini, M., & Colombi, M. (2022) · Cells · doi:10.3390/cells11244040 · Cited by 19 · see citing works
Pearce, G., Bell, L., Pezaro, S., & Reinhold, E. J. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20206957 · Cited by 17 · see citing works
Schubart, J. R., Schaefer, É., Knight, D. R. T., Mills, S. E., & Francomano, C. A. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1365712 · Cited by 15 · see citing works
Ribeiro, J. A. D. S., Gomes, G., Aldred, A., Desuó, I. C., & Giacomini, L. A. (2024) · The Yale Journal of Biology and Medicine · doi:10.59249/wgrs1619 · Cited by 14 · see citing works
Wang, T. J., Stecco, A., Hakim, A. J., & Schleip, R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125587 · Cited by 14 · see citing works
Akkaya, K. U., Burak, M., Erturan, S., Yıldız, R., Yıldız, A., & Elbasan, B. (2022) · Musculoskeletal Science and Practice · doi:10.1016/j.msksp.2022.102642 · Cited by 13 · see citing works
Hertel, A., Black, W. R., Malloy-Walton, L. E., Martin, J. R., & Jones, J. T. (2024) · Current Cardiology Reviews · doi:10.2174/011573403x271096231203164216 · Cited by 11 · see citing works
Mudie, K., Ramiller, A., Whittaker, S., & Phillips, L. E. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1324879 · Cited by 9 · see citing works
Liaghat, B., Juul‐Kristensen, B., Faber, D. A., Christensen, E. O., Søgaard, K., Skou, S. T., Søndergaard, J., & Juhl, C. B. (2024) · British Journal of Sports Medicine · doi:10.1136/bjsports-2023-107563 · Cited by 8 · see citing works
Long COVID and hypermobility spectrum disorders have shared pathophysiology
Ganesh, R., & Munipalli, B. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1455498 · Cited by 7 · see citing works
Dickinson, M., Erridge, S., Warner-Levy, J. J., Clarke, E., McLachlan, K., Coomber, R., Holden, W., Rucker, J., Platt, M. W., & Sodergren, M. H. (2025) · ACR Open Rheumatology · doi:10.1002/acr2.70024 · Cited by 7 · see citing works
Winschel, J. M., Albright, J. A., Testa, E. J., Kent, V. F., Byrne, R. A., He, E. W., Daniels, A. H., & Owens, B. D. (2024) · JSES Reviews Reports and Techniques · doi:10.1016/j.xrrt.2024.03.006 · Cited by 6 · see citing works
Clark, N., Johnson, M., Rangan, A., Kottam, L., Hogarth, A., Scott, S., & Swainston, K. (2024) · Clinical Rheumatology · doi:10.1007/s10067-024-07172-3 · Cited by 6 · see citing works
Sweerts, K. W. E., Mujagic, Z., Keszthelyi, D., & Conchillo, J. M. (2025) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.18471 · Cited by 6 · see citing works
Ahimaz, P. R., Kramer, T., Swaroop, P., Mitchell, M., Hernan, R., Anyane‐Yeboa, K., & Pereira, E. M. (2022) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.62945 · Cited by 5 · see citing works
Chuchin, J., & Ornstein, T. J. (2023) · Disability and Rehabilitation · doi:10.1080/09638288.2023.2268520 · Cited by 4 · see citing works
Sweerts, K. W. E., Vork, L., Mujagic, Z., Conchillo, J. M., & Keszthelyi, D. (2025) · Digestive Diseases and Sciences · doi:10.1007/s10620-025-09206-5 · Cited by 2 · see citing works
Black, W. R., Black, L. L., Goldstein‐Leever, A., Fox, L. S., Pratt, L. R., & Jones, J. T. (2024) · Rheumatology International · doi:10.1007/s00296-024-05676-4 · Cited by 2 · see citing works
Gaudiani, M. A., Samuel, L. T., Burkhart, R. J., Acuña, A. J., Rosneck, J. T., & Kamath, A. F. (2022) · Archives of Orthopaedic and Trauma Surgery · doi:10.1007/s00402-022-04737-2 · Cited by 1 · see citing works
Jones, E., & Carrieri, D. (2025) · Disability and Rehabilitation · doi:10.1080/09638288.2025.2517246 · Cited by 1 · see citing works
Crompton, C. J., Efthimiou, T. N., Dockrell, D., & Berg, K. M. (2026) · BMC Medicine · doi:10.1186/s12916-026-04713-2 · Cited by 1 · see citing works
Benign Joint Hypermobility Syndrome in Clinical Practice
Karpovich, Y. L., Pronko, T. P., Карпович, Ю. И., & Петрашевич, А. В. (2022) · Рецепт · doi:10.34883/pi.2022.25.4.016 · Cited by 1 · see citing works
Karpovich, Y. L., & Pronko, T. P. (2024) · Regional blood circulation and microcirculation · doi:10.24884/1682-6655-2024-23-2-30-37 · Cited by 1 · see citing works
Family Medicine Research on Health Equity, Addiction, and Eating Breakfast—Just for Starters
Seehusen, D. A., Bowman, M. A., & Ledford, C. J. W. (2021) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2021.04.210199
The Most Frequently Read Articles of 2021
Bowman, M. A., Seehusen, D. A., Ledford, C. J. W., & Lupo, P. (2022) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2022.04.220203
Joint Hypermobility Syndrome: A Narrative Review
de Oliveira, J. L., Nogueira, I. A., Nogueira, C. T., Lopes, S. V. P., Teles, G. S., Rocha, R. S. D. C., Morais, P. I., Carvalho, A. B. C., Pereira, P. H. D. S., & Alencar, D. J. P. (2023) · American Journal of Internal Medicine · doi:10.11648/j.ajim.20231103.12
Karpovich, Y. L., Pronko, T. P., & Мелешко, А. В. (2023) · Journal of the Grodno State Medical University · doi:10.25298/2221-8785-2023-21-3-243-249
Kaushik, P. (2023) · Annals of Advanced Biomedical Sciences · doi:10.23880/aabsc-16000213
Barzamini, S., Rahmani, K., Shiari, R., Parvaneh, V. J., & Yeganeh, M. H. (2024) · Journal of Comprehensive Pediatrics · doi:10.5812/jcp-141109
Diagnostic signs of hypermobility spectrum disorders in adults and children
Trisvetova, E. L. (2024) · Medical news of the North Caucasus · doi:10.14300/mnnc.2024.19018
Thia, I., & Jeewa, F. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.114013
Karpovich, Y. L., & Pronko, T. P. (2024) · Кардиология в Беларуси · doi:10.34883/pi.2024.16.6.006
Shoulder Instability in Hyperlaxity and Collagen Disorders
Vuletić, F., & Bøe, B. (2025) · Springer eBooks · doi:10.1007/978-3-031-81389-4_11
Association of benign joint hypermobility syndrome in children with mitral valve prolapse
Abdelrahman, E., Abdelmotaleb, G. S., Hassane, M. R. A., & El-Deen, E. M. N. (2025) · DOAJ (DOAJ: Directory of Open Access Journals) · doi:10.1186/s43054-025-00410-6
Dinh, P. V., Johnson, J. M., Reiad, T. A., Bruni, D. F., Bosco, A., Milner, J., Owens, B. D., Marcaccio, S. E., Daniels, A. H., & Hsu, R. Y. (2025) · Foot & Ankle International · doi:10.1177/10711007251363246
Parasympathetic and Sympathetic Nervous System Dysfunction and Monitoring
DePace, N. L., Soloway, S., Yayac, M. F., & Colombo, J. (2025) · Springer eBooks · doi:10.1007/978-3-031-88769-7_13
DePace, N. L., Soloway, S., Yayac, M. F., & Colombo, J. (2025) · Springer eBooks · doi:10.1007/978-3-031-88769-7_7
Clark, N., Johnson, M., Adamson, J., Rangan, A., Kottam, L., & Swainston, K. (2026) · Rheumatology International · doi:10.1007/s00296-025-06062-4
Cinquina, V., Carini, G., Chiarelli, N., Vezzoli, M., Bertini, V., Venturini, M., Gandy, W., Colombi, M., & Ritelli, M. (2026) · Clinical Proteomics · doi:10.1186/s12014-026-09588-2
Covbasiuc, Y. I., Троицкая, Е. А., & Кобалава, Ж. Д. (2026) · Fundamental and Clinical Medicine · doi:10.23946/2500-0764-2026-11-1-37-47
Brandt, L., Kondratek, M., Kim, L., Ohanian, H., Schneck, K., Vukasovich, C., Woźny, A., & Ziskey, C. (2026) · International Journal of Rehabilitation Research · doi:10.1097/mrr.0000000000000713
Guyton, G. P. (2026) · Clinical Orthopaedics and Related Research · doi:10.1097/corr.0000000000004049
Дворниченко, М. В., Белоусов, М. В., Melnik, Y. Y., Zinovyev, E. А., Sudakov, A. D., Loban, E. R., Byakov, V. A., & Ivanova, E. A. (2026) · JOURNAL of SIBERIAN MEDICAL SCIENCES · doi:10.31549/2542-1174-2026-10-2-146-162
Kwiatkowska, M., Palian, J., Huzarska, K., Kurzyński, S., & Baraniecka, A. (2026) · Quality in Sport · doi:10.12775/qs.2026.64.73746
Czorniej, K. P., & Kułąk, W. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1856830
Flynn, K. J., Ransom, J. T., & McGrath, D. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1945865
Vilotti, L., DePace, N., Colombo, J., & Benn, A. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1967117
- Authors
- Atwell, K., Michael, W., Dubey, J., James, S., Martonffy, A., Anderson, S., Rudin, N., & Schrager, S.
- Affiliations
- University of Wisconsin–Madison (US)
- Venue
- The Journal of the American Board of Family Medicine
- Published
- 2021-07
- Volume
- 34
- Issue
- 4
- Pages
- 838-848
- ISSN
- 1557-2625 (ISSN-L)
- 1558-7118
- OpenAlex
- W3184166575
- Cited by
- 52
- References
- 36
- Citations by year
- 2026: 9 · 2025: 10 · 2024: 13 · 2023: 11 · 2022: 6 · 2021: 3
- FWCI
- 1.22
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Locations
- The Journal of the American Board of Family Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Connective tissue disorders research
- Health Sciences › Medicine › Pharmacology › Musculoskeletal pain and rehabilitation
- Health Sciences › Medicine › Psychiatry and Mental health › Fibromyalgia and Chronic Fatigue Syndrome Research
- Keywords
- hypermobility spectrum disorders, hypermobile Ehlers-Danlos syndrome, connective tissue diseases, joint hypermobility, chronic pain, fatigue, diagnosis, primary care management, patient education, multidisciplinary care, incidence and prevalence, pathophysiology
- MeSH terms
- Diagnosis, Differential, Humans, Joint Instability, Primary Health Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-06.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-06.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review